EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Increased Risk of Intracranial Hemorrhage and Mortality Following Thrombolysis in Patients with Stroke and Active Cancer

Kwon-Duk Seo, Sang Hyun Suh, Ji Hoe Heo, Byung Moon Kim, Kyung-Yul Lee

Journal of Neurosonology and Neuroimaging · 2018

DOI: 10.31728/jnn.2018.00020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosonology and Neuroimaging, 2018. Verfasst von Kwon-Duk Seo und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The cerebrovascular disease is not uncommon in cancer patients.However, the effectiveness and safety of thrombolysis for acute ischemic stroke in this patient group has not been established well.We aimed to investigate the outcomes of thrombolysis for the patients suffering from cancer.

Methods

We conducted a retrospective analysis using database of patients who had received thrombolysis in two university hospitals.Included patients were those who had received intravenous thrombolysis or endovascular therapy.We compared mortality, and the incidence of hemorrhagic transformation (HT) and symptomatic intracerebral hemorrhage (sICH) between patients with active cancer and those without.

Results

Among a total of 627 patients, 42 (6.7%)had a medical history of active cancer.The mortality was higher in cancer patients than the others (27.5% vs. 13.7%,p=0.023).The existence of cancer was one of the factors to increases the risk of mortality (adjusted odds ratio, 3.354; 95% confidence interval, 1.416-7.947;p=0.006).From the 240 patients treated with intravenous thrombolysis only, the incidence of HT (53.8% vs. 16.3%, p=0.003), sICH (30.8% vs. 2.2%, p=0.001), and mortality (41.7% vs. 8.1%, p=0.003) was higher in cancer patients than the patients without.

Conclusion

Comorbidity with cancer raised the risk of mortality in patients when treated with thrombolysis.The patients with cancer had more bad outcomes with intravenous thrombolysis only.Our data suggest that the decision of thrombolytic treatment for cancer patients requires careful consideration.

Zitieren

APA

Seo, K., Suh, S. H., Heo, J. H., Kim, B. M., & Lee, K. (2018). Increased Risk of Intracranial Hemorrhage and Mortality Following Thrombolysis in Patients with Stroke and Active Cancer. Journal of Neurosonology and Neuroimaging. https://doi.org/10.31728/jnn.2018.00020

Vancouver

Seo K, Suh SH, Heo JH, Kim BM, Lee K. Increased Risk of Intracranial Hemorrhage and Mortality Following Thrombolysis in Patients with Stroke and Active Cancer. Journal of Neurosonology and Neuroimaging. 2018. doi:10.31728/jnn.2018.00020

BibTeX
@article{Seo2018,
  author = {Seo, Kwon-Duk and Suh, Sang Hyun and Heo, Ji Hoe and Kim, Byung Moon and Lee, Kyung-Yul},
  title = {Increased Risk of Intracranial Hemorrhage and Mortality Following Thrombolysis in Patients with Stroke and Active Cancer},
  journal = {Journal of Neurosonology and Neuroimaging},
  year = {2018},
  doi = {10.31728/jnn.2018.00020}
}
Kostenlos starten →